NEW YORK (GenomeWeb) – Provista Diagnostics said today that it has closed $5.25 million in preferred funding generated by existing investors exercising warrants from a previous financing round.

The firm plans to use the money for continued commercial development and clinical testing of its proteomic diagnostics, as well as for management hires and general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.